Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06695156 · ClinicalTrials.gov registry record · NA
Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: A Single Arm Study
A NA study of Migraine and Migraine With or Without Aura, sponsored by Maharishi International University.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06695156: Active NA study of Migraine and Migraine With or Without Aura, sponsored by Maharishi International University.
NCT06695156 is a NA study of Migraine and Migraine With or Without Aura that is active but no longer recruiting, run by Maharishi International University. The registered enrollment target is 30 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06695156, a NA study of Migraine and Migraine With or Without Aura, is active but no longer recruiting, sponsored by Maharishi International University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 participants recruited from migraine treatment facilities and support groups in the US.
Primary Outcome
Frequency and functionality will be measured by the data recorded in the migraine App.
Conditions Studied
Interventions
- BEHAVIORAL Meditation
Study Locations (1)
District of Columbia
- Georgetown Headache Center and DC area - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-08-28 |
| Est. Completion | 2026-05 |
| Phase | NA |
What the registry record for NCT06695156 still lists
NCT06695156 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which Meditation is the first listed.
NCT06695156 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06695156 about?
NCT06695156 is a clinical study titled "Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: A Single Arm Study". This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 participants recruited from migraine treatment facilities and support groups in the US.
What is the current status of trial NCT06695156?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-28. Estimated completion is 2026-05.
What conditions does trial NCT06695156 study?
This clinical trial studies the following conditions: Migraine, Migraine With or Without Aura.
What interventions are being tested in trial NCT06695156?
The interventions under investigation include: Meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06695156?
This trial is sponsored by Maharishi International University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06695156 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06695156's enrollment target sits among peer trials
30 92nd of 102 higher than 8 of 102 other Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI